Search Results - "de Araújo, Rogério Agenor"
-
1
Survival differences between women and men in the non-reproductive cancers: Results from a matched analysis of the surveillance, epidemiology, and end-results program
Published in Frontiers in public health (06-01-2023)“…Men with non-reproductive cancers have a discrepant outcome compared to women. However, they differ significantly in the incidence of cancer type and…”
Get full text
Journal Article -
2
Analysis of the surgical approach in prostate cancer staging: results from the surveillance, epidemiology and end results program
Published in Scientific reports (19-06-2023)“…Surgery is not used as a criterion for staging prostate cancer, although there is evidence that the number of analyzed and affected lymph nodes have prognosis…”
Get full text
Journal Article -
3
The effect of delayed treatment in breast cancer patients: How much is too late? An experience of a single-center study effect of surgery delay in survival
Published in Surgical oncology (01-09-2022)“…Proper treatment is critical for control and curative intent in breast cancer. Delays in receiving treatment can influence patients' prognoses. Retrospective,…”
Get full text
Journal Article -
4
The effectiveness of radiotherapy in preventing disease recurrence after breast cancer surgery
Published in Surgical oncology (01-05-2022)“…The locoregional management of breast cancer has a critical impact on prognosis. This study aimed to analyze the effectiveness of radiotherapy against the…”
Get full text
Journal Article -
5
The benefits of trastuzumab in the treatment of HER2+ breast cancer as a function of exposure time
Published in Ecancermedicalscience (20-01-2022)“…Breast cancer is a heterogeneous disease with overexpression of several receptors, such as human epidermal receptor 2 (HER2), which is a prognostic and…”
Get full text
Journal Article -
6
The elusive Luminal B breast cancer and the mysterious chemokines
Published in Journal of cancer research and clinical oncology (01-11-2023)“…Purpose Invasive ductal breast cancer (IDC) is heterogeneous. Staging and immunohistochemistry (IH) allow for effective therapy but are not yet ideal. Women…”
Get full text
Journal Article -
7
Peptide vaccines in breast cancer: The immunological basis for clinical response
Published in Biotechnology advances (01-12-2015)“…This review discusses peptide-based vaccines in breast cancer, immune responses and clinical outcomes, which include studies on animal models and phase I,…”
Get full text
Journal Article -
8
Operable breast cancer: How not to worsen the prognosis, especially in triple negative and stage II tumors
Published in Surgical oncology (01-09-2021)“…Oncological surgery must follow some fundamental principles to be truly curative, one of which is the resection of the tumor with surgical margins free of…”
Get full text
Journal Article -
9
A hierarchical approach to combine histological grade and immunohistochemical factors to identify high-risk luminal breast cancers
Published in Ecancermedicalscience (04-05-2022)“…BackgroundThe luminal subtype accounts for ~70% of newly diagnosed breast cancer patients. Although it has a better prognosis, approximately 30% of them…”
Get full text
Journal Article -
10
Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker
Published in Ecancermedicalscience (2022)“…Epidermal growth factor receptor (EGFR) overexpression has been considered a poor prognostic factor in breast cancer. A prospective study of 206 women with…”
Get full text
Journal Article -
11
Prognosis value of lymphovascular invasion in patients with invasive ductal breast carcinoma according to lymph node metastasis status
Published in Ecancermedicalscience (2022)“…Tumour lymphovascular invasion is not routinely assessed in all pathology services, and whether reporting it quantitatively or qualitatively is the main factor…”
Get full text
Journal Article -
12
Undetected αKlotho in serum is associated with the most aggressive phenotype of breast cancer
Published in Molecular and clinical oncology (01-04-2022)“…Klotho, a cellular anti-senescence protein, is related to antitumor actions, growth regulation, proliferation and invasiveness in several types of tumor,…”
Get full text
Journal Article -
13
Desmoplastic Small Round Cell Tumor: Report of 2 Cases Treated with Chemotherapy Alone or in Combination with Bevacizumab
Published in Case reports in oncology (15-02-2014)“…Here, we present 2 case reports of patients with desmoplastic small round cell tumor (DSRCT), a very rare and aggressive mesenchymal cancer, and we discuss…”
Get full text
Journal Article -
14
The current staging and classification systems of breast cancer and their pitfalls: Is it possible to integrate the complexity of this neoplasm into a unified staging system?
Published in Critical reviews in oncology/hematology (01-10-2022)“…Breast cancer is one of the leading causes of cancer death in women worldwide due to its variable aggressiveness and high propensity to develop distant…”
Get full text
Journal Article -
15
Chemokines and the extracellular matrix: Set of targets for tumor development and treatment
Published in Cytokine (Philadelphia, Pa.) (01-08-2021)“…•The matrix contains proteins, fibronectin, laminin, collagen and glycosaminoglycans.•In addition to interactions with cells, an interaction matrix also with…”
Get full text
Journal Article -
16
Far beyond the usual biomarkers in breast cancer: a review
Published in Journal of Cancer (01-01-2014)“…Research investigating biomarkers for early detection, prognosis and the prediction of treatment responses in breast cancer is rapidly expanding. However, no…”
Get full text
Journal Article -
17
-
18
Expression of epidermal growth factor receptor (EGFR) in blood and tumor in patients with breast carcinoma: Prognostic analysis
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e15013 Background: EGFR acts on tumor progression and can be quantified in the blood (bEGFR) and in the tumor (tEGFR). This study analyzed the…”
Get full text
Journal Article -
19
EGF (epidermal growth factor) receptor expression in blood: Prognostic biomarker in overall survival (OS) of patients with non-metastatic triple negative (TN) breast carcinoma
Published in Journal of clinical oncology (20-05-2019)“…Abstract only e14518 Background: EGF acts on tumor progression and its receptor can be measured by immunohistochemistry, or in the blood by immunoenzymatic…”
Get full text
Journal Article -
20
Undetected [alpha]Klotho in serum is associated with the most aggressive phenotype of breast cancer
Published in Molecular and clinical oncology (01-04-2022)“…Klotho, a cellular anti-senescence protein, is related to antitumor actions, growth regulation, proliferation and invasiveness in several types of tumor,…”
Get full text
Journal Article